Stabilising normal and mis-sense variant alpha-glucosidase.

about

Therapeutic approaches in glycogen storage disease type II/Pompe Disease.

P2860

Q37329535-9DAECD6B-2477-4C31-B713-473F224491A5

P2860

Stabilising normal and mis-sense variant alpha-glucosidase.

Item

http://www.wikidata.org/entity/Q51805825

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Stabilising normal and mis-sense variant alpha-glucosidase.

@en

Stabilising normal and mis-sense variant alpha-glucosidase.

@nl

type

Item

label

Stabilising normal and mis-sense variant alpha-glucosidase.

@en

Stabilising normal and mis-sense variant alpha-glucosidase.

@nl

prefLabel

Stabilising normal and mis-sense variant alpha-glucosidase.

@en

Stabilising normal and mis-sense variant alpha-glucosidase.

@nl

P1476

Stabilising normal and mis-sense variant alpha-glucosidase.

@en

P2093

Debbie Lang

http://www.w3.org/2001/XMLSchema#string

Doug A Brooks

http://www.w3.org/2001/XMLSchema#string

John J Hopwood

http://www.w3.org/2001/XMLSchema#string

Peter J Meikle

http://www.w3.org/2001/XMLSchema#string

Revecca Kakavanos

http://www.w3.org/2001/XMLSchema#string

P2860

High-level production of recombinant human lysosomal acid alpha-glucosidase in Chinese hamster ovary cells which targets to heart muscle and corrects glycogen accumulation in fibroblasts from patients with Pompe disease

Pharmacological enhancement of beta-hexosaminidase activity in fibroblasts from adult Tay-Sachs and Sandhoff Patients.

Chemical chaperones increase the cellular activity of N370S beta -glucosidase: a therapeutic strategy for Gaucher disease.

Chemical chaperone therapy for brain pathology in G(M1)-gangliosidosis.

Enzyme replacement and enhancement therapies for lysosomal diseases.

Enzyme replacement therapy in late-onset Pompe's disease: a three-year follow-up.

The change in the pH 4 and pH 6 forms of alpha-glucosidase in cultured amniotic fluid cells and its implication in prenatal diagnosis of Pompe's disease.

Correlation of acid alpha-glucosidase and glycogen content in skin fibroblasts with age of onset in Pompe disease.

Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk.

Isolation and characterisation of a recombinant, precursor form of lysosomal acid alpha-glucosidase.

P304

4365-4370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.FEBSLET.2006.06.096

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

580

http://www.w3.org/2001/XMLSchema#string

P577

2006-07-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6938426

http://www.w3.org/2001/XMLSchema#string

P698

16846599

http://www.w3.org/2001/XMLSchema#string

Stabilising normal and mis-sense variant alpha-glucosidase.

about

P2860

P2860

Stabilising normal and mis-sense variant alpha-glucosidase.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698